Fjarde AP Fonden Fourth Swedish National Pension Fund increased its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 109.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 39,425 shares of the company’s stock after acquiring an additional 20,564 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in Henry Schein were worth $3,232,000 at the end of the most recent quarter.
Other hedge funds have also added to or reduced their stakes in the company. YorkBridge Wealth Partners LLC grew its holdings in shares of Henry Schein by 5.2% in the second quarter. YorkBridge Wealth Partners LLC now owns 570 shares of the company’s stock valued at $104,000 after acquiring an additional 28 shares in the last quarter. Sun Life Financial INC lifted its stake in Henry Schein by 8,185.7% in the second quarter. Sun Life Financial INC now owns 580 shares of the company’s stock valued at $106,000 after purchasing an additional 573 shares during the last quarter. Lee Financial Co purchased a new position in Henry Schein in the second quarter valued at approximately $161,000. Acrospire Investment Management LLC lifted its stake in Henry Schein by 150.0% in the second quarter. Acrospire Investment Management LLC now owns 1,000 shares of the company’s stock valued at $183,000 after purchasing an additional 600 shares during the last quarter. Finally, HM Payson & Co. purchased a new position in Henry Schein in the second quarter valued at approximately $204,000. 63.60% of the stock is owned by institutional investors.
WARNING: This story was originally posted by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this story on another site, it was stolen and republished in violation of U.S. & international trademark & copyright laws. The original version of this story can be viewed at https://sportsperspectives.com/2017/11/20/henry-schein-inc-hsic-stake-boosted-by-fjarde-ap-fonden-fourth-swedish-national-pension-fund.html.
HSIC has been the topic of several research analyst reports. Robert W. Baird set a $95.00 price objective on Henry Schein and gave the company a “buy” rating in a research note on Thursday, October 19th. Northcoast Research upgraded Henry Schein from a “neutral” rating to a “buy” rating and set a $109.00 price objective on the stock in a research note on Monday, August 7th. UBS AG reiterated a “buy” rating on shares of Henry Schein in a research note on Friday, September 15th. Craig Hallum upgraded Henry Schein from a “hold” rating to a “buy” rating in a research note on Tuesday, November 7th. Finally, TheStreet downgraded Henry Schein from a “b” rating to a “c+” rating in a research note on Monday, November 6th. Two equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and seven have given a buy rating to the stock. The stock presently has an average rating of “Hold” and an average target price of $89.88.
Shares of Henry Schein, Inc. (NASDAQ:HSIC) opened at $69.12 on Monday. The stock has a market capitalization of $10,850.00, a price-to-earnings ratio of 19.39, a price-to-earnings-growth ratio of 1.95 and a beta of 1.03. Henry Schein, Inc. has a 12-month low of $65.28 and a 12-month high of $93.50. The company has a current ratio of 1.55, a quick ratio of 0.86 and a debt-to-equity ratio of 0.30.
Henry Schein (NASDAQ:HSIC) last posted its earnings results on Monday, November 6th. The company reported $0.87 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.90 by ($0.03). The company had revenue of $3.16 billion for the quarter, compared to analysts’ expectations of $3.05 billion. Henry Schein had a return on equity of 19.71% and a net margin of 4.52%. The company’s revenue was up 10.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.84 EPS. sell-side analysts forecast that Henry Schein, Inc. will post 3.6 EPS for the current year.
Henry Schein declared that its board has authorized a stock repurchase program on Monday, September 18th that permits the company to repurchase $400.00 million in outstanding shares. This repurchase authorization permits the company to buy up to 6.3% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company’s board believes its stock is undervalued.
In other Henry Schein news, SVP Paul Rose sold 2,126 shares of the stock in a transaction on Wednesday, September 6th. The stock was sold at an average price of $172.51, for a total transaction of $366,756.26. Following the sale, the senior vice president now owns 17,841 shares in the company, valued at $3,077,750.91. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 1.19% of the company’s stock.
About Henry Schein
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.